NASDAQ:ESLA | Profit Breakdown | Estrella Immunopharma, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$2.08M-$2.31M-$2.31M
2026-03-31-$2.29M-$2.29M-$2.29M
2025-12-31-$613,199.00-$613,199.00-$613,174.00
2025-09-30-$4.8M-$4.8M-$4.8M
2025-06-30-$5.54M-$5.54M-$5.54M
2025-03-31-$2.1M-$2.1M-$2.1M
2024-09-30-$3.38M-$3.38M-$3.38M
2024-06-30-$3.95M-$3.95M-$3.95M
2024-03-31-$469,530.00-$469,530.00-$469,530.00
2023-12-31-$1.02M-$1.02M
2023-09-30-$1.87M-$1.87M-$1.87M
2023-06-30-$2.73M-$54,927.00-$2.73M
2023-03-31-$2.74M-$43,860.00-$2.74M
2022-12-31-$2.76M-$69,755.00-$2.76M
2022-09-30-$2.89M-$344,863.00-$2.89M
2022-06-30-$423,765.00-$359,586.00-$359,586.00
2022-03-31-$144,940.00-$141,252.00-$141,252.00
2021-12-31-$136,654.00-$135,797.00-$135,797.00
2021-09-30-$108,114.00-$107,547.00-$107,547.00
2021-06-30-$3,559.00-$3,555.00-$3,555.00
2021-03-31-$819.00-$819.00-$819.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$13.06M-$13.06M-$13.06M
2024-06-30-$7.31M-$7.31M-$7.31M
2023-06-30-$11.11M-$11.11M-$11.11M
2022-12-31-$1.57M-$915,456.00-$996,104.00
2021-12-31-$249,146.00-$247,718.00-$247,718.00